Hopkins company raises $110 million to develop cancer test

A startup developing technology originating at Johns Hopkins that offers early detection of cancers launched Thursday with $110 million in Series A funding, a record Series A round for a Johns Hopkins company. Thrive Earlier Detection Corp. will develop CancerSeek, a liquid biopsy that tests for eight different forms of common cancers. “This is a milestone moment ...

To purchase a reprint of this article, contact reprints@thedailyrecord.com.